We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleResults From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial.AuthorsDamaj, Gandhi; Gressin, Rémy; Bouabdallah, Krimo; Cartron, Guillaume; Choufi, Bachra; Gyan, Emmanuel; Banos, Anne; Jaccard, Arnaud; Park, Sophie; Tournilhac, Olivier; Collela, Jean-Marc Schiano-de; Voillat, Laurent; Joly, Bertrand; Le Gouill, Steven; Saad, Alain; Cony-Makhoul, Pascale; Vilque, Jean-Pierre; Sanhes, Laurence; Schmidt-Tanguy, Aline; Bubenheim, MichaelPublicationJournal of Clinical Oncology, 2013, Vol 31, Issue 1, p104ISSN0732-183xPublication typearticleDOI10.1200/JCO.2012.43.7285